- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05109247
Prediction of Spontaneous Onset of Labor at Term (PREDICT)
March 25, 2023 updated by: Federico Migliorelli, University Hospital, Geneva
The study intends to develop a predictive model of spontaneous onset of labor between 39 and 41 weeks of pregnancy in women carrying singletons and without indication of delivery before this date.
The main hypothesis is that a combination of clinical, ultrasonographic, biochemical and/or biophysical variables will allow to differentiate women who will spontaneously trigger their labors from those who will require an induction by the term of their pregnancies.
A tool of this kind should aid in the individualization of the management of the final weeks of pregnancy and, at the light of recent evidence, provide support to the decision-making processes.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
429
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Federico E Migliorelli, MD, PhD
- Phone Number: +34 607 31 32 57
- Email: Federico.Migliorelli@hcuge.ch
Study Contact Backup
- Name: Begoña Martinez de Tejada, MD, PhD
- Phone Number: +41 22 372 64 79
- Email: Begona.MartinezDeTejada@hcuge.ch
Study Locations
-
-
-
Basel, Switzerland, 4031
- Universitatsspital Basel
-
Geneva, Switzerland, 1211
- Hôpitaux universitaires de Genève
-
-
Vaud
-
Lausanne, Vaud, Switzerland, 1011
- Centre Hospitalier Universitaire Vaudois
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Pregnant women at 38+5 - 39 weeks of gestation who will deliver at the centers in which the study will be carried out.
Description
Inclusion Criteria:
- Alive fetus
- Singletons
- Cephalic presentation
- Intact membranes
- Gestational age ≥ 38 weeks and 5 days
Exclusion Criteria:
- Fetal malformations
- Symptomatic uterine contractions
- Contraindication for vaginal delivery
- Medical indication of induction of labor or elective cesarean delivery
- Maternal desire to induce labor
- Maternal negative to enrollment
- Language barrier
- Inability to give consent
Specific Exclusion Criteria for Pregnolia System (if any of these criteria is present, the measurement of cervical stiffness using Pregnolia aspiration device will not be performed):
- Müllerian anomalies with two cervices
- Severe vaginal bleeding
- Cervical dilatation
- Known HIV
- Visible, symptomatic cervical or vaginal infections
If one of the following conditions is present on the cervix at the 12 o'clock position:
- Nabothian cyst
- Cervical myomas
- Cervical condylomas
- Squamous intraepithelial lesion
- Conization/LEEP2/LLETZ3
- Cervical endometriosis
- Cervical tears
- Cervical dysplasia
- Large ectopy, for which it is not possible to find a suitable location near the ectopy where native tissue is present
- Large scar tissue, for which it is not possible to find a suitable location near the scar where native tissue is present.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Spontaneous versus induced onset of labor
Time Frame: 3 weeks
|
Number of participants who will spontaneously go into labor between the 39th and the 41st week of pregnancy versus number of participants requiring an induction of labor during the 41st week of pregnancy due to advanced gestational age
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gestational age at spontaneous onset of labor
Time Frame: 2 weeks
|
Time from sample collection at 39 weeks of pregnancy to spontaneous onset of labor
|
2 weeks
|
Gestational age at spontaneous onset of labor
Time Frame: 1 week
|
Time from sample collection at 40 weeks of pregnancy to spontaneous onset of labor
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 22, 2019
Primary Completion (Actual)
December 31, 2022
Study Completion (Actual)
December 31, 2022
Study Registration Dates
First Submitted
October 26, 2021
First Submitted That Met QC Criteria
October 26, 2021
First Posted (Actual)
November 5, 2021
Study Record Updates
Last Update Posted (Actual)
March 28, 2023
Last Update Submitted That Met QC Criteria
March 25, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 19-261
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor Onset
-
Oregon Health and Science UniversityMedical Research Foundation, Oregon; Bloomlife Technologies; OHSU School of NursingUnknownLabor Onset | Cervical Dilation | Labor Onset BiomarkersUnited States
-
University of TennesseeRecruitingLabor Onset and Length Abnormalities | Labor Long | Prolonged Labor | Labor; PoorUnited States
-
Centre Hospitalier Universitaire de NīmesTerminatedObstetric Labor, Premature | Obstetric Labor | Labor OnsetFrance
-
Hospital General Universitario Gregorio MarañonUnknownLabor Pain | Labor Onset | Parturition | Natural Childbirth | Humanizing Deliver | First Labor StageSpain
-
Shaare Zedek Medical CenterUnknownLabor Onset | GravidityIsrael
-
mohamed abosenaAin Shams UniversityCompletedLabor Onset and Length AbnormalitiesEgypt
-
Ain Shams UniversityCompletedLabor Onset and Length AbnormalitiesEgypt
-
Dilafor ABCompletedLabor Onset and Length AbnormalitiesFinland, Sweden
-
University of California, San FranciscoWithdrawnLabor Onset and Length AbnormalitiesUnited States
-
Centro Hospitalar Lisboa NorteRecruitingLabor; Forced or Induced, Affecting Fetus or Newborn | Labor Onset and Length AbnormalitiesPortugal